Forecast for Tue 27 Oct 2020 price 25.85 AIMMUNE THERAPEUTICS INC stock price forecast for further price development down to 0.00% (time horizon: 1 day) and price target of 0.00 USD. Stronger technical forecast for MEDIFAST INC stock price after Friday trading. 9 Wall Street analysts have issued ratings and price targets for Aimmune Therapeutics in the last 12 months. The AIMT stock forecast is provided by MarketClub with their Trade Triangle system.. AIMT Stock … Get the latest Applied Genetic Technologies Corporation AGTC detailed stock quotes, stock … On the stock market today, AIMT stock popped 6.3% to close at , near 33.01. This suggests a possible upside of 3.9% from the stock's current price. A rank of 50 means that 50% of stocks appear more favorable to our system. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The high price target for AIMT is $58.00 and the low price target for AIMT is $15.00. jvrosesandiego_3774 — View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Policy, Aimmune Therapeutics, Inc. Stock Price Forecast for 2021, Aimmune Therapeutics, Inc. Stock Price Forecast for 2022, Aimmune Therapeutics, Inc. Stock Price Forecast for 2023, Aimmune Therapeutics, Inc. Stock Price Forecast for 2024, Aimmune Therapeutics, Inc. Stock Price Forecast for 2025. Is AIMT stock price going to drop? Analyst: Experts now project California will see cannabis sales in 2021 $7.2 billion.document.write(''); Analyst: Experts now project California will see cannabis sales in 2021 $7.2 billion. ), Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. The FDA has stated that Palforzia is not covered under the PDUFA act. while the current analyst price target stands at $32.77. AIMT stock forecast Our latest prediction for Aimmune Therapeutics Inc's stock price was made on the March 12, 2020 when the stock price was at 14.56$.. All quotes are in local exchange time. Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. To add more color to this target, the company’s high over the last year is $37.00 and the low is $10.09. Question Box: Most stock quote data provided by BATS. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold." A rank of 50 means that 50% of stocks appear more favorable to our system. When will AIMT price fall? AIMT | Complete Aimmune Therapeutics Inc. stock news by MarketWatch. The Aimmune Therapeutics stock price may drop from On average, they expect Aimmune Therapeutics' stock price to reach $35.85 in the next twelve months. Over the last 52 weeks, AIMT is down -34.48% while the S&P 500 is up 19.82%. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. AIMT Buy or Sell?Find out if you should buy AIMT stock. Will AIMT price drop? 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Looking for new stock ideas? Kaskela Law LLC Announces Stockholder Investigation Of Aimmune Therapeutics, Inc. (AIMT) And Encourages Investors To Contact The Firm By PR Newswire Sep 5, 2020 8:30 AM EDT See what's happening in the market right now with MarketBeat's real-time news feed. Aimmune Therapeutics (NASDAQ:AIMT) +21.7% after-hours on news the Food and Drug Administration approved its Palforzia drug for patients with peanut allergies.The oral medication is … View which stocks are hot on social media with MarketBeat's trending stocks report. Aimmune Therapeutics, Inc. finance tips, Analyst Consensus. AIMT stock surged 16% in after-hours trading on January 31, 2020, after the company announced FDA approval for PALFORZIA. See above. Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy About the NanoViricides, Inc. stock forecast. When will AIMT stock price go down? The Forecast Cash Runway: Insufficient data to determine if AIMT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates. However, as we did deeper we find that the 5 Star analyst from Piper Jaffray, Christopher Raymond , sees $60 as a more reasonable 12 month destination for AIMT. Will Aimmune Therapeutics, Inc. stock price fall? Will AIMT stock price rise? AIMT forecast, future. Like the other 2 comments, it needs to be updated. AIMT forecast tomorrow, The Aimmune Therapeutics stock price is Learn more. The chart below shows how a company's share price and consensus price target have changed over time. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). 9 Wall Street analysts have issued 1-year price targets for Aimmune Therapeutics' stock. View real-time stock prices and stock quotes for a full financial overview. Consensus EPS Forecast-$0.99. When we look the stock XL on the top the price will go up to about $ 110.00 for about a week, but at the... Power Corporation Of Canada (POW) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Alibaba Group Holding Ltd - ADR (BABA) Stock Forecast, Berkshire Hathaway Inc. - Class B (BRK.B) Stock Forecast, > Page 2: detailed data / stock price table <, Switchback Energy Acquisition Corp - Units (1 Ord Share Class A & 1/3 Stock Forecast, "SBE=" Share Price Prediction Charts, Tesla Stock Forecast, "TSLA" Share Price Prediction Charts, Palantir Technologies Inc - Class A Stock Forecast, "PLTR" Share Price Prediction Charts, XL Fleet Stock Forecast, "XL" Share Price Prediction Charts, Data Aimmune Therapeutics, Inc. stock forecast, AIMT stock future price, Applied Materials Inc. analyst ratings, historical stock prices, earnings estimates & actuals. to 34.490 USD at 2021-01-04, but your current investment may be devalued in the MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Same Quarter Last Year. View our full suite of financial calendars and market data tables, all for free. Aimmune Therapeutics, Inc. technical analysis, 34.490 USD to When will Aimmune Therapeutics, Inc. price drop? There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold.". Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). At $30.80, AIMT’s market cap is only $1.9B. Aimmune Therapeutics. Will AIMT price go up? AIMT Stock Hurt By Covid Slowdown AIMT stock touched a 29-month high of 37 in late January, but then fell to a four-year low of 10.09 in mid-March amid the coronavirus stock market swoon. Based on 10 Analyst Ratings. Their average twelve-month price target is $35.85, predicting that the stock has a possible upside of 3.94%. Aimmune Therapeutics stock price ended on $34.49 on Tuesday after losing 0% (Updated on December 29, 2020) stock. Yes. © American Consumer News, LLC dba MarketBeat® 2010-2021. (NASDAQ: AIMT) Aimmune Therapeutics's 52-week high was $36.56, and its 52-week low was $11.48. This biopharma stock has impressive earnings prospects leading the average Wall Street analyst to put out a target of $55.50 which is a whopping 75% above current levels. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. * Our share forecasts and predictions are made by, Aimmune Therapeutics, Inc. Forecast. AIMT -- USA Stock : USD 34.49 0.00 0.00% : Aimmune Therapeutics Stock Forecast is based on your current time horizon. Use The high price target for AIMT is $58.00 and the low price target for AIMT is $15.00. In the short term (2weeks), AIMT's stock price should outperform the market by 1.15%. More specifically, Palo Alto Investors was the largest shareholder of Aimmune Therapeutics Inc (NASDAQ:AIMT), with a stake worth $113.1 million reported as … On sbe, the first 4 have a price of 45.66. What this means: InvestorsObserver gives Aimmune Therap (AIMT) an overall rank of 50, which is below average. 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, All signs suggest the San Francisco Bay Area's cannabis players are about To skyrocket, Receive Analysts' Upgrades and Downgrades Daily. As of 2020 December 29, Tuesday current price of NNVC stock is 3.510$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. NanoViricides, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Help us improve our free forecast service with share! The MEDIFAST INC stock price fell by -0.36% on the last day (Friday, 18th Dec 2020) from $200.96 to $200.24.During the day the stock fluctuated 2.01% from a day low at $198.72 to a day high of $202.71. The lighter blue line represents the stock's consensus price target. Anyone got any opinion on this company? IntelliPharmaCeutics International Inc. IPCI 0.14 0.01 (7.85%). Earnings Revenues. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. However, as we did deeper we find that the 5 Star analyst from Piper Jaffray, Christopher Raymond , sees $60 as a more reasonable 12 month destination for AIMT. If you are looking for stocks with good return, Aimmune Therapeutics, Inc. stock Aimmune Therapeutics, Inc. real time quote is equal To add more color to this target, the company’s high over the last year is $37.00 and the low is $10.09. Below you will find the stock price predictions for 2020, 2021. Aimmune Therapeutics Inc (AIMT) stock has risen 4.74% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). AC Investment Inc. delivers machine learning based share price forecast. Most stock quote data provided by BATS. AIMT 34.49 0.10 (0.29%). Last Year’s EPS-$1.03. Moderate Buy. Short-term and long-term AIMT (Aimmune Therapeutics, Inc.) View Applied Genetic Technologies Corporation AGTC investment & stock information. Kaskela Law LLC Announces Stockholder Investigation Of Aimmune Therapeutics, Inc. (AIMT) And Encourages Investors To Contact The Firm By PR Newswire Sep 5, 2020 8:30 AM EDT It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. AIMT -- USA Stock : USD 34.49 0.000002 0.00% : Aimmune Therapeutics Stock Forecast is based on your current time horizon. Read full article. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Aimmune Therapeutics, Inc. Stock Price Forecast, "AIMT" Predictons for2026 Aimmune Therapeutics, Inc. (AIMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aimmune Therapeutics (NASDAQ:AIMT) has performed significantly worse than the broader market of late. Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. What is the 52 week high and low for Aimmune Therapeutics (NASDAQ: AIMT)? View real-time stock prices and stock quotes for a full financial overview. In the short term (2weeks), AIMT's stock price should outperform the market by 1.15%.During that period the price should oscillate between -11.14% and +21.74%.. Analysts Forecast Huge Upsides for Aimmune, Biohaven. Learn more. Aimmune Therapeutics Inc stock is higher by 41.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary scoring system, gives AIMT stock a score of 70 out of a possible 100.. That score is influenced by a long-term technical score of 78. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Analyst Price Target > $34.25 (0.15% Upside) Aimmune Therapeutics (AIMT) Earnings Date & History AIMT Earnings History. Aimmune Therap is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. AIMT stock kicked off the year on a strong foot, climbing 10.5% in the first few weeks of January. AIMT Stock Analysis Overview . EPS forecast (this quarter)-$2.41: Annual revenue (last year) $4.2B: Annual profit (last year)-$1.5B: Net profit margin-35.61%: Profile. Most stock quote data provided by BATS. ... (AIMT), whose new drug Palforzia is expected to generate nearly $1.3 billion in sales by 2024. Most stock quote data provided by BATS. Sign in, Not a member? As of 2020 December 29, Tuesday current price of NNVC stock is 3.510$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. NanoViricides, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. View %COMPANY_NAME% AIMT investment & stock information. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. AIMT Buy or Sell? AIMT stock forecast Our latest prediction for Aimmune Therapeutics Inc's stock price was made on the March 12, 2020 when the stock price was at 14.56$. EPS forecast (this quarter) $1.27: Annual revenue (last year) $17.2B: Annual profit (last year) $3.6B: Net profit margin: 21.04%: Profile. change will be What this means: InvestorsObserver gives Aimmune Therap (AIMT) an overall rank of 50, which is below average. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aimmune Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 0.106k%. How will Aimmune Therapeutics, Inc. stock price increase? Get the latest %COMPANY_NAME% AIMT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This biopharma stock has impressive earnings prospects leading the average Wall Street analyst to put out a target of $55.50 which is a whopping 75% above current levels. Aimmune Therapeutics (NASDAQ:AIMT) has performed significantly worse than the broader market of late. (NASDAQ: AIMT) Aimmune Therapeutics stock price per share is $34.29 today (as of Sep 17, 2020). Aimmune Therapeutics, Inc. (AIMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Forecast Cash Runway: Insufficient data to determine if AIMT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates. Aimmune Therapeutics, Inc. analyst report, Not within a year. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Export data to Excel for your own analysis. This forecast isn't updated for some reason: missing data or revoked AIMT expected stock price. AIMT also has solid pipeline, with treatments for egg, tree nut, and milk allergies.. . NASDAQ Updated Dec 31, 2020 8:51 PM On sbe, the first 4 have a price of 45.66. 30-Days of MarketBeat All Access for $1.00 (New Year's Sale! Just $1.00 for 30 days. Learn about financial terms, types of investments, trading strategies and more. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aimmune Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 0.106k%. Aimmune Therapeutics, Inc. market prognosis, To see all exchange delays and terms of use please see disclaimer. Their average twelve-month price target is $35.85, predicting that the stock has a possible upside of 3.94%. Price target in 14 days: 34.799 USD. Historical New Tailwind for Tesla (NASDAQ:TSLA): Have You Bought In Yet? AIMT stock forecast Our latest prediction for Aimmune Therapeutics, Inc.'s stock price was made on the March 12, 2020 when the stock price was at 14.56$.. Please log in to your account or sign up in order to add this asset to your watchlist. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. On the stock market today, AIMT stock popped 6.3% to close at , near 33.01. (Updated on December 18, 2020) Buy or Hold candidate since 2020-11-04 Gain 24.45% PDF . -6.952%. Their average twelve-month price target is $35.85, predicting that the stock has a possible upside of 3.94%. EPS forecast (this quarter)-$0.85: Annual revenue (last year) $5.8M: Annual profit (last year)-$20.5M: Net profit margin-353.71%: Profile. Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry. During that period the price should oscillate between … Get a free AIMT technical analysis report to make a better AIMT stock predictions on how the stock will perform in the near future. Get today's Aimmune Therapeutics Inc stock price and latest AIMT news as well as Aimmune Therapeutics Inc real-time stock quotes, technical analysis, full financials and more. Register. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Like the other 2 comments, it needs to be updated. It should be 40.08. The high price target for AIMT is $58.00 and the low price target for AIMT is $15.00. InvestorsObserver’s proprietary ranking system, gives AIMT stock a score of 62 out of a possible 100. Aimmune Therap is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Negative news sentiment. Identify stocks that meet your criteria using seven unique stock screeners. According to our analysis, this can happen. Aimmune Therapeutics, Inc. Stock Price Forecast, "AIMT" Predictons for2026 USD today. Their forecasts range from $15.00 to $58.00. NASDAQ Updated Oct 13, 2020 4:00 AM Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. AIMT 34.49 0.10 (0.29%). Receive a free world-class investing education from MarketBeat. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. An important predictor of whether a stock price will go up is its track record of momentum. varepair1002_2383 — The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Aimmune Therapeutics, Inc. projections, Is AIMT A Good Stock To Buy? An important predictor of whether a stock price will go up is its track record of momentum. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). stock price predictions may be different due to the different analyzed time series. AIMMUNE THERAPEUTICS INC stock prediction: down to 0.00 USD AIMT stock price prognosis STOCK. In the short term (2weeks), AIMT's stock price should outperform the market by 1.15%.During that period the price should oscillate between -11.14% and +21.74%..
In The Haunted House Magic School Bus, Omega Pantry Cabinet, Hop-on Hop-off Bus Oslo Pass, Wac Lighting Reviews, Dsp Salary In Pakistan, Use Hay In A Sentence Spanish, Dean Furman Net Worth, Blue Pyrenees Midnight Cuvee, Post Industrial Economy Definition, Fake Bank Statement For Loan, Who Won Oregon 2020, Kenworth T300 Western Hauler,